Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Combined Intranasal Esketamine and Brief Cognitive Behavioral Therapy for Suicidal Ideation - A Randomized Controlled Trial

NCT07396220 is registered in ClinicalTrials.gov with University of California, San Diego as lead sponsor.

NCT NCT07396220
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07396220 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Combined Intranasal Esketamine and Brief Cognitive Behavioral Therapy for Suicidal Ideation - A Randomized Controlled Trial
Lead sponsor
University of California, San Diego
Phase
Not applicable
Overall status
Enrolling by invitation
Start date
January 9, 2026
Completion date
January 31, 2029
Enrollment
56 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

suicidal ideation